Results 281 to 290 of about 117,210 (347)

Immunological landscape of radiation‐induced cardiac injury

VIEW, Volume 6, Issue 6, December 2025.
Immunological Landscape of Radiation‐Induced Cardiac Injury: As the irradiation time increases, the proportions and functions of immune cells change. At 7 days post‐irradiation, the population is primarily composed of inflammatory cells (neutrophils and MHCII−_Ccr2−_Lyve1+ macrophages), with functional changes predominantly reflecting an inflammatory ...
Huan Liu, Dan Ou, Han Zhao, Ran Wu, Keman Liao, Jianyi Zhao, Zhou Li, Zhe Xu, Yuerui Wang, Lu Cao, Yingying Lin, Jia‐Yi Chen   +11 more
wiley   +1 more source

Ferret model of bleomycin-induced lung injury shares features of human idiopathic pulmonary fibrosis. [PDF]

NPJ Regen Med
Wu S, Driver I, Luo M, Miyazaki H, Shambhu S, Popov D, Yang L, Wang J, Ma J, Guo J, Atha J, Tata A, Hoffman EA, Wang Y, Tata PR, Jensen MB, Engelhardt JF, Sontake V, Liu X.   +18 more
europepmc   +1 more source

Cardiac magnetic resonance quantification of epicardial adipose tissue identifies subclinical cardiac dysfunction in asymptomatic obesity: A multicenter cross‐sectional study

VIEW, Volume 6, Issue 6, December 2025.
Epicardial adipose tissue (EAT) is implicated in obesity‐related heart failure, yet its association with subclinical cardiac dysfunction in asymptomatic obese individuals remains unclear. This prospective multicenter study used cardiac magnetic resonance to quantify EAT volume and assess cardiac morphology and systolic/diastolic function in 87 ...
Xu Wang, Hang Zhao, Jiang Yue, Yezi Chai, Jing Ma, Meng Jiang, Jun Pu   +6 more
wiley   +1 more source

Reply to Zeng: Redefining Accelerated Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis: Uncovering Treatment Effects and Novel Triggers. [PDF]

Am J Respir Crit Care Med
Nathan SD, Kim HC, King C, Chandel A.
europepmc   +1 more source

DLD‐HLNP/P@IR780 for efficient lung‐parenchyma accumulation to treat idiopathic pulmonary fibrosis

VIEW, Volume 6, Issue 6, December 2025.
DLD‐HLNP/P@IR780 was synthesized to target to lung and treat IPF by releasing pirfenidone. It could effectively traverse pulmonary ECB and accumulate in lung parenchyma by IR780 binding to CD300LF and MRC1 which are abundantly and specifically expressed on pulmonary endothelial cell and pulmonary macrophages.
Mengzhu Wang, Na Zhuang, Juan Feng, Cheng Qian   +3 more
wiley   +1 more source

Rethinking idiopathic pulmonary fibrosis management: clinical impact of nerandomilast as a new therapeutic agent. [PDF]

Ann Med Surg (Lond)
Iqbal MU, Iqbal MZ, Abu Nahla U.
europepmc   +1 more source

Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients

, 2007
C.S. Zimmermann, Celso Ricardo Fernandes Carvalho, K.R. Silveira, W.P.S. Yamaguti, E.V. Moderno, J.M. Salge, R.A. Kairalla, C.R.R. Carvalho   +7 more
openalex   +1 more source

Reduced Mitochondrial Adenine Nucleotide Translocase 1 (ANT1) Correlates With Aging‐Associated Airway Remodeling

Aging Cell, Volume 24, Issue 12, December 2025.
Adenine nucleotide translocase 1 (ANT1), a mitochondrial ATP transporter, is decreased in the lung epithelium of aged adults and aged mice correlating to pathogenic airway changes. Loss of ANT1 correlates with increased cellular senescence and changes in COL8A1 in the airway epithelium of the lung.
Roshani Jha, Jian Shi, Maggie J. Sedgwick, Justin Sui, Timothy E. Corcoran, Corrine R. Kliment   +5 more
wiley   +1 more source

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis. [PDF]

Sci Rep
Hamada N, Tokunaga S, Yanagihara T, Tsubouchi K, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Yatera K, Kawasaki M, Yoshida M, Maeyama T, Fujita M, Mashimoto A, Furuyama K, Torii R, Suzuki K, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Okamoto I, Nakanishi Y.   +23 more
europepmc   +1 more source